Dioscorea polystachya Turcz. Extract attenuates osteoclastogenesis and ovariectomy-induced bone loss in rats.

Researchers investigated whether Chinese yam (Dioscorea polystachya), a traditional East Asian herb used in herbal medicine to strengthen bones, could help prevent bone loss similar to what occurs after menopause. The study used laboratory tests and animal models to examine how the herb affects bone-destroying cells called osteoclasts. In laboratory experiments, extract from Chinese yam roots significantly reduced the formation and activity of osteoclasts. The researchers then tested the extract in rats whose ovaries had been removed to simulate menopause-related bone loss. After eight weeks of treatment, rats given the Chinese yam extract showed dose-dependent protection against bone deterioration compared to untreated rats. Micro-CT scans revealed better preservation of the spongy bone structure inside bones, and blood tests showed reduced markers of bone breakdown. The herb worked by suppressing genes and proteins that promote osteoclast development and bone resorption. These findings suggest that Chinese yam may offer a natural approach to preventing osteoporosis in postmenopausal women by slowing excessive bone breakdown. While this herb is often used alongside acupuncture in traditional East Asian medicine practices for musculoskeletal health, this particular study focused on the herbal extract alone rather than acupuncture treatment. The results support the traditional use of this herb for bone health, though human clinical trials are still needed. If you're interested in herbal medicine or integrative approaches to bone health, seek care from a qualified licensed acupuncturist or herbalist trained in traditional East Asian medicine.

This study evaluated the anti-osteoporotic effects of Dioscorea polystachya root extract (DRE) through in vitro and in vivo models. In bone marrow-derived macrophages stimulated with RANKL and M-CSF, DRE significantly inhibited osteoclast differentiation and suppressed expression of key osteoclastogenic genes including Nfatc1, c-Fos, Ctsk, Mmp9, and Acp5, as confirmed by TRAP staining and qRT-PCR. In ovariectomized rats treated orally for eight weeks, DRE dose-dependently attenuated trabecular bone loss, reduced serum ALP and TRAP levels, and preserved trabecular architecture on micro-CT analysis. Immunohistochemistry revealed marked reduction in cathepsin K-positive osteoclasts in DRE-treated groups versus OVX controls. The mechanisms involve suppression of osteoclast differentiation and activity in estrogen-deficient states. Clinical implications: DRE demonstrates potential as a natural therapeutic agent for postmenopausal osteoporosis prevention by targeting excessive bone resorption. This validates traditional use of Dioscorea polystachya (Shan Yao) for bone strengthening in East Asian herbal medicine.